Description
This generic medication, approved under ANDA207388 by Alvogen Inc., contains a combination of amphetamine salts (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate) in oral tablet form. It's a Schedule II controlled substance, available in strengths equivalent to 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg, and 30 mg of amphetamine, used as a central nervous system stimulant. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 5 mg,cll | HTML | Access the FDA dataset for Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 5 mg,cll — ANDA 207388 submitted by Mylan Institutional LLC | Open resource |